Watts Gwilliam & Co., LLC Bristol Myers Squibb CO Transaction History
Watts Gwilliam & Co., LLC
- $474 Billion
- Q4 2024
A detailed history of Watts Gwilliam & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 5,060 shares of BMY stock, worth $298,287. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,060
Previous 5,120
1.17%
Holding current value
$298,287
Previous $269 Million
7.58%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,602Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.35 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.48 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.59 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.6 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...